Ozempic and Wegovy selected for next round of Medicare drug price negotiations
By Tami Luhby, CNN (CNN) — Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday. But how much consumers will ultimately save depends on many factors, including the
Continue Reading